7
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Different Functional States of Topoisomerase II can be Discriminated by Orthovanadate Sensitivity in Multi-drug Resistant Human Leukemic Cells

, , &
Pages 381-383 | Received 03 Jul 1992, Published online: 01 Jul 2009

References

  • Gieseler F., Boege F., Biersack H., Spohn B., Clark M., Wilms. Alteration of Topoisomerases as a molecular mechanism of drug resistance. Annals of Hemalology 1991; 62, Abstract 12, No. 25
  • Boege F., Gieseler F., Biersack H., Clark M. 1991, Structural and functional heterogeneity of topoisomerase II in a multi-drug resistant HL-60 cell line revealed by anion-exchange chromatography and chromato-focussing: J. Chro-matogr., in press
  • Drake F. H., Hofmann G. A., Bartus H. F., Mattern M. R., Crooke S. T., Mirabelli C. K. Biochemical and pharmacological properties of p 170 and p 180 forms of topoisomerase II:. Biochemistry 1989; 28: 8154–8160
  • Liu L. F., Davis J. L. Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases. Nucl. Acid Res. 1981; 9: 3979–3989
  • Beck W. T., Danks M. K., Suttle D. P. Multidrug resistance associated with alterations in topoisomerase II activity. Cancer Res. Clin. Oncol. 1990; 116: 1145
  • Suttle D. P., Bugg B. Y., Danks M. K., Beck W. T. Expression of an altered DNA topoisopmerase II in multidrug resistant (at-MDR) CEM cells. Proc. Am. Ass. Cancer Res. 1990; 31: 358
  • Saijo M., Enomoto T., Hanaoka F., Ui M. Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: Phosphorylation of topoisomerase and modification of its activity. Biochemistry 1990; 29: 583–590
  • Heck M. M., Hittelman W. N., Earnshaw W. C. In vivo phosphorylation of the 170-kDa form of eukariotic DNA topoisomerase II. J. Biol. Chem. 1989; 264: 15161–16164
  • Sahyoun N., Wolf M., Besterman J., Hsieh T.-S., Sander M., LeVine H., III, Chang K.-J., Cuatrecasas P. Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc. Natl. Acad. Sci. 1986; 83: 1603–1607
  • Zwelling L. A., Chan D., Hinds M., Mayes J., Silberman L. E., Blick M. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Res. 1988; 48: 6625–6633
  • Gieseler F., Boege F., Clark M. Alteration of topoisomerase II action is a possible mechanism of HL-60 cell differentiation. Environ. Health Persp. 1990; 88: 183–185
  • Osheroff H., Shelton E. R., Brutlag D. L. DNA Topoisomerase II from Drosophila melanogaster: Relaxation of supercoiled DNA. J. Biol. Chem. 1983; 258: 9536–9543

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.